17 alpha-hydroxyprogesterone caproate has been researched along with Endometrioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akobdzhanian, MA; Lipets, VIa | 1 |
| Mori, T; Noda, Y; Ozasa, H | 1 |
2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Endometrioma
| Article | Year |
|---|---|
[Structural characteristics of the pathologically changed uterus after treatment with sex hormones].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Endometriosis; Endometrium; Female; Humans; Hydroxyprogesterones; Leiomyoma; Middle Aged; Testosterone; Uterine Neoplasms | 1985 |
Progesterone increases serum CA-125 in endometriosis.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adult; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Endometriosis; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Follicular Phase; Humans; Hydroxyprogesterones; Injections, Intramuscular; Middle Aged; Progesterone; Radioimmunoassay; Time Factors; Uterine Neoplasms | 1987 |